Stock Market Blog
Daily stock market analysis, trade alerts, and trading education from Ross Givens and the Traders Agency team.

FDA Rejects Capricor's Deramiocel BLA a Second Time, Cites Insufficient Effectiveness Data
Capricor Therapeutics said it received a second FDA Complete Response Letter for Deramiocel, citing insufficient evidence of effectiveness and unspecified clinical deficiencies, as it reviews operating costs with about $198.5 million in cash.

Two Tanker Attacks Reported Near Oman's Khasab as Strait of Hormuz Attacks Hit Highest Level Since Iran War Began
UKMTO reported two tanker attacks by unidentified projectiles near Oman's Khasab on Saturday, as data compiled by maritime organizations showed Strait of Hormuz attacks at their highest level since the Iran war began in late February.

S&P 500 Falls Into Correction as AI Stock Rout Wipes Out Nasdaq's 2026 Gains
The S&P 500 entered a correction and the Nasdaq composite turned negative for 2026 after a 3.7% drop led by steep losses in Nvidia, AMD, Micron and Broadcom, amid AI valuation and financing concerns.

Global Payments Shares Surge After Report GTCR Weighing ~$50 Billion Takeover
Global Payments shares jumped after Bloomberg and Seeking Alpha reported GTCR is weighing a roughly $50 billion takeover, reportedly with financing help from other buyout firms.

Stock Market Today: Consumer Staples Leads While S&P 500 Slips
Consumer Staples led the session while the S&P 500 slips. See the validated market scorecard, sector performance, and what traders are watching next.

Apollo and Goldman Sachs Price $44 Billion SpaceX GPU Financing, Billed as Largest to Date
Apollo and Goldman Sachs said they priced about $44 billion of senior and subordinated notes to fund GPUs for SpaceX, with lease schedules expected to start in the first half of 2027.

Intuit Reports First-Quarter Revenue Growth, Lowers Credit Karma Guidance for Fiscal 2027
Intuit's fiscal first-quarter release showed 19% QuickBooks Online Accounting growth and a lowered Credit Karma revenue outlook for fiscal 2027, plus a pending $3.68 billion Mailchimp sale to Bending Spoons.

Dividend Investing for Beginners
Dividend investing for beginners: learn how yields, payout ratios, and DRIPs work, and why a 9% yield can be a warning sign.

Merck's Sac-TMT Hits Overall-Survival Goal in Gastroesophageal Cancer Trial, Falls Short on Progression-Free Survival
Merck said its Phase 3 TroFuse-015 trial of sacituzumab tirumotecan met its primary overall-survival endpoint in previously treated gastroesophageal adenocarcinoma, but missed the secondary progression-free survival goal. No effect-size data was disclosed.

How Traders Lose When They Change the Rules
It’s easy to set rules before buying a stock. The test comes when following them means selling something you want to keep.

Keysight Technologies Reports Record Fourth-Quarter and Fiscal 2026 Results, Issues Q1 FY2027 Guidance
Keysight reported record fourth-quarter and fiscal 2026 revenue and earnings, fourth-quarter orders of $2.339 billion, and guided first-quarter fiscal 2027 revenue and non-GAAP EPS higher.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
